Feeds:
Posts
Comments

Posts Tagged ‘Mayo Clinic’

JUNE 24: WALL ST JOURNAL: Shares of Medarex Inc. (MEDX) surged Monday on news that two patients taking the biopharmaceutical company’s prostate cancer treatment in a mid-stage trial are now cancer free. READ MORE>

Read Full Post »

JUNE 20: DINTZ.COM: Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardised hormone treatment and radiation therapy. The men were participating in a clinical trial of an immuno-therapeutic agent called MDX-010 or ipilimumab. READ MORE>

Read Full Post »

REUTERS:  Cholesterol-lowering statin drugs may protect men against prostate cancer and other urological complaints.

A clinical study following 2447 men over 15 years found those taking statins were less likely to develop prostate cancer. Just 6% of men on statins were diagnosed with prostate cancer, with non-statin users three times more likely to develop the disease, Mayo Clinic researchers have reported at the American Urological Association meeting in Chicago.  READ MORE>

Read Full Post »